Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis

Hamada,Shinsuke; Ito,Keiichi; Kuroda,Kenji; Sato,Akinori; Asakuma,Junichi; Horiguchi,Akio; Seguchi,Kenji; Asano,Tomohiko

doi:10.3892/mco.2014.432

January-February 2015 Volume 3 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2015 Volume 3 Issue 1

Full Size Image

Article

Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis

Authors:
- Shinsuke Hamada
- Keiichi Ito
- Kenji Kuroda
- Akinori Sato
- Junichi Asakuma
- Akio Horiguchi
- Kenji Seguchi
- Tomohiko Asano
View Affiliations / Copyright

Affiliations: Department of Urology, National Defense Medical College, Tokorozawa, Saitama 3598513, Japan
Pages: 63-68
|
Published online on: September 29, 2014

https://doi.org/10.3892/mco.2014.432
Expand metrics +

Abstract

The prognosis of patients with renal cell carcinoma (RCC) and liver metastasis (LM) is poor. We evaluated the clinical characteristics, prognosis and prognostic factors of RCC patients with LM. A total of 25 patients who underwent radical or partial nephrectomy (Nx) for RCC between November, 1980 and April, 2013 at the National Defense Medical College, Tokorozawa, Saitama, Japan, with LM at initial presentation or following Nx, were included in this study. The association between prognosis following development of LM and clinicopathological parameters was analyzed. The Cox proportional hazards regression model was used to identify prognostic predictors. The median cancer‑specific survival (CSS) following LM diagnosis was 10.6 months. The presence of sarcomatoid differentiation, Eastern Cooperative Oncology Group performance status (ECOG PS) ≥2, C‑reactive protein ≥1.0 mg̸dl, corrected calcium ≥10 mg̸dl and presence of multiple organ metastases, were identified as CSS predictors. The multivariate analysis identified ECOG PS ≥2 as an independent CSS predictor. Nine patients survived for >20 months following LM diagnosis and 1 patient, who received treatment with tyrosine kinase inhibitors (TKIs) for LM, exhibited stable disease for 5 years. Nine patients underwent local LM treatment. Two patients, who underwent hepatic resection, survived for 55.1 and 22 months, respectively. In conclusion, RCC patients with LM may benefit from local LM treatment if they have a limited number of metastases in addition to LM and if their ECOG PS is satisfactory. Indeed, a proportion of RCC patients with LM benefit from TKI therapy. Furthermore, RCC patients with LM and ECOG PS ≥2 apparently have a poor prognosis, regardless of local or systemic therapies.

View Figures

View References

1	Linehan WM, Walther MM, Alexander RB and Rosenberg SA: Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute. Semin Urol. 11:41–43. 1993.PubMed/NCBI
2	Naito S, Yamamoto N, Takayama T, et al: Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol. 57:317–325. 2010. View Article : Google Scholar
3	Shinohara N, Nonomura K, Abe T, et al: A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma. Cancer Sci. 103:1695–1700. 2012. View Article : Google Scholar
4	Motzer RJ, Bacik J, Murphy BA, Russo P and Mazumdar M: Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 20:289–296. 2002. View Article : Google Scholar : PubMed/NCBI
5	Leibovich BC, Cheville JC, Lohse CM, et al: A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol. 174:1759–1763. 2005. View Article : Google Scholar : PubMed/NCBI
6	Shuto T, Inomori S, Fujino H and Nagano H: Gamma knife surgery for metastatic brain tumors from renal cell carcinoma. J Neurosurg. 105:555–560. 2006. View Article : Google Scholar : PubMed/NCBI
7	Toyoda Y, Shinohara N, Harabayashi T, et al: Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone. Eur Urol. 52:163–168. 2007. View Article : Google Scholar : PubMed/NCBI
8	Yasuda Y, Fujii Y, Yuasa T, et al: Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma. Int J Clin Oncol. 18:877–883. 2013. View Article : Google Scholar : PubMed/NCBI
9	Hoshi S, Jokura H, Nakamura H, et al: Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol. 9:618–627. 2002. View Article : Google Scholar : PubMed/NCBI
10	Zeng H, Li X, Yao J, et al: Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib. Urol Int. 83:482–485. 2009. View Article : Google Scholar : PubMed/NCBI
11	Molina AM, Ginsberg MS and Motzer RJ: Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib. Med Oncol. 28:1527–1529. 2011. View Article : Google Scholar : PubMed/NCBI
12	Alves A, Adam R, Majno P, et al: Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol. 10:705–710. 2003. View Article : Google Scholar : PubMed/NCBI
13	Staehler MD, Kruse J, Haseke N, et al: Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 28:543–547. 2010.PubMed/NCBI
14	Sobin LH, Gospodarowicz MK and Wittekind Ch: TN. classification of Malignant Tumors7th. Wiley-Blackwell; West Sussex, UK: 2009
15	Ito K, Yoshii H, Asakuma J, et al: Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens. Jpn J Clin Oncol. 39:588–594. 2009. View Article : Google Scholar : PubMed/NCBI
16	Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic paramaters in renal cell carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
17	Gore ME, Hariharan S, Porta C, et al: Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer. 117:501–509. 2011. View Article : Google Scholar : PubMed/NCBI
18	Langan RC, Ripley RT, Davis JL, et al: Liver directed therapy for renal cell carcinoma. J Cancer. 3:184–190. 2012. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles